Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: Role of Cr(VI) chelation

Toxicology

Volumn 291, Issue 1-3, 2012, Pages 93-101

  Molina Jijón, Eduardo ^a   Zarco Márquez, Guillermo ^a,b   Medina Campos, Omar Noel ^a   Zataraín Barrón, Zyanya Lucía ^c   Hernández Pando, Rogelio ^c   Pinzón, Enrique ^d   Zavaleta, Rosa Marina ^a   Tapia, Edilia ^b   Pedraza Chaverri, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cr(VI) chelation; Deferoxamine; Nephrotoxicity; Potassium dichromate; Renoprotective

Indexed keywords

CATALASE; CREATININE; DEFEROXAMINE; DICHROMATE POTASSIUM; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; N ACETYL BETA GLUCOSAMINIDASE; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CHELATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOLOGY; IC 50; IN VITRO STUDY; KIDNEY DISEASE; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; ANTIDOTES; CATALASE; CHELATING AGENTS; CHROMIUM; DEFEROXAMINE; GLUTATHIONE; INDICATORS AND REAGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; POTASSIUM DICHROMATE; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 84155171243     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.11.003     Document Type: Article

References (35)

1. al-Harbi M.M., Osman A.M., al-Gharably N.M., al-Bekairi A.M., al-Shabanah O.A., Sabah D.M., Raza M. Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats. Chemotherapy 1995, 41:448-454.
2. Arora A.S., Gores G.J. The role of metals in ischemia/reperfusion injury of the liver. Semin. Liver Dis. 1996, 16:31-38.
3. Banner W.J., Koch M., Capin D.M., Hopf S.B., Chang S., Tong T.G. Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds. Toxicol. Appl. Pharmacol. 1986, 30:142-147.
4. 7. Free Radic. Biol. Med. 2003, 34:1390-1398.
5. Bulucu F., Oktenli C., Kenar L., Ocal R., Koc B., Inal V., Yamanel L., Yaman H., Sanisoglu Y.S., Aydin A. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with adriamycin-induced nephrotic syndrome. J. Nephrol. 2008, 21:576-583.
6. Cohen M.D., Kargacin B., Klein C.B., Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 1993, 23:255-281.
7. Cohen M.D., Sisco M., Prophete C., Yoshida K., Chen L.C., Zelikoff J.T., Smee J., Holder A.A., Stonehuerner J., Crans D.C., Ghio A.J. Effects of metal compounds with distinct physicochemical properties on iron homeostasis and antibacterial activity in the lungs: chromium and vanadium. Inhal. Toxicol. 2010, 22:169-178.
8. De Domenico I., Ward D.M., Kaplan J. Specific iron chelators determine the route of ferritin degradation. Blood 2009, 114:4546-4551.
9. El-Far M.A., Bakr M.A., Farahat S.E., Abd El-Fattah E.A. Glutathione peroxidase activity in patients with renal disorders. Clin. Exp. Nephrol. 2005, 9:127-131.
10. Fernández-Checa J.C., Kaplowitz N. The use of monochlorobimane to determine hepatic GSH levels and synthesis. Anal. Biochem. 1990, 190:212-219.
11. García-García J.D., Rodríguez-Zavala J.S., Jasso-Chávez R., Mendoza-Cózatl D., Moreno-Sánchez R. Chromium uptake, retention and reduction in photosynthetic Euglena gracilis. Arch. Microbiol. 2009, 191:431-440.
12. Guelman L.R. Deferoxamine antioxidant activity on cerebellar granule cells γ-irradiated in vitro. Neurotoxicol. Teratol. 2004, 26:477-483.
13. Guerrero-Beltrán C.E., Calderón-Oliver M., Tapia E., Medina-Campos O.N., Sánchez-González D.J., Martínez-Martínez C.M., Ortiz-Vega K.M., Franco M., Pedraza-Chaverri J. Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicol. Lett. 2010, 15:278-285.
14. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action?. Free Radic. Biol. Med. 1989, 7:645-651.
15. Halliwell B., Gutteridge J.M. Free Radicals in Biology and Medicine 2007, Oxford University Press, New York.
16. Jasso-Chávez R., Pacheco-Rosales A., Lira-Silva E., Gallardo-Pérez J.C., García N., Moreno-Sánchez R. Toxic effects of Cr(VI) and Cr(III) on energy metabolism of heterotrophic Euglena gracilis. Aquat. Toxicol. 2010, 100:329-338.
17. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 10:65-87.
18. Kadikoylu G., Bolaman Z., Demir S., Balkaya M., Akalin N., Enli Y. The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum. Exp. Toxicol. 2004, 23:29-34.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
20. Matsuki N., Torii Y., Saito H. Effects of iron and deferoxamine on cisplatin-induced emesis: further evidence for the role of free radicals. Eur. J. Pharmacol. 1993, 248:329-331.
21. Molina-Jijón E., Tapia E., Zazueta C., El Hafidi M., Zatarain-Barrón Z.L., Hernández-Pando R., Medina-Campos O.N., Zarco-Márquez G., Ismael Torres I., Pedraza-Chaverri J. Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radic. Biol. Med. 2011, 51:1543-1557.
22. Norseth T. The carcinogenicity of chromium and its salts. Br. J. Ind. Med. 1986, 43:649-651.
23. Ozdemir E., Dokucu A.I., Uzunlar A.K., Ece A., Yaldiz M., Oztürk H. Experimental study on effects of deferoxamine mesilate in ameliorating cisplatin-induced nephrotoxicity. Int. Urol. Nephrol. 2002, 33:127-131.
24. Papazisis G., Pourzitaki C., Sardeli C., Lallas A., Amaniti E., Kouvelas D. Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. Pharmacol. Res. 2008, 57:73-78.
25. 7-induced nephrotoxicity. BMC Nephrol. 2005, 6:4.
26. Pedraza-Chaverri J., Yam-Canul P., Chirino Y.I., Sánchez-González D.J., Martínez-Martínez C.M., Cruz C. Protective effects of garlic powder against potassium dichromate-induced oxidative stress and nephrotoxicity. Food Chem. Toxicol. 2008, 46:619-627.
27. Petronilho F., Constantino L., de Souza B., Reinke A., Martins M.R., Fraga C.M., Ritter C., Dal-Pizzol F. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats. Nephrol. Dial. Transplant. 2009, 24:2077-2082.
28. Ritter C., Reinke A., Andrades M., Martins M.R., Rocha J., Menna-Barreto S., Quevedo J., Moreira J.C., Dal-Pizzol F. Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit. Care Med. 2004, 32:2079-2083.
29. Saltzman B.E. Microdetermination of chromium with diphenylcarbazide by permanganate oxidation. Improved method of oxidation and color development. Anal. Chem. 1952, 4:1016-1020.
30. Skalova S. The diagnostic role of urinary N-acetyl-beta-d-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove) 2005, 48:75-80.
31. Stohs S.J., Bagchi D., Hassoun E., Bagchi M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J. Environ. Pathol. Toxicol. Oncol. 2000, 19:201-213.
32. Sugiyama M. Role of physiological antioxidant in Cr(VI) induced cellular injury. Free Radic. Biol. Med. 1992, 12:397-407.
33. Susa N., Ueno S., Furukawa Y., Sugiyama M. Protective effect of deferoxamine on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Arch. Toxicol. 1997, 71:345-350.
34. Taras M.J., Greenberg A.E., Hoak R.D., Rand M.C. Standard Methods for Examination of Water and Wastewater 1971, American Public Health Association, New York.
35. Younes M., Sause C., Siegers C.P., Lemoine R. Effect of deferrioxamine and diethyldithiocarbamate on paracetamol-induced hepato- and nephrotoxicity. The role of lipid peroxidation. J. Appl. Toxicol. 1988, 8:261-265.